Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.8K Sell
683
-42
-6% -$4.92K 0.02% 170
2026
Q1
$87.2K Buy
725
+2
+0.3% +$231 0.03% 166
2025
Q4
$76.1K Buy
723
+3
+0.4% +$282 0.02% 164
2025
Q3
$60.5K Sell
720
-798
-53% -$65.7K 0.02% 185
2025
Q2
$120K Buy
1,518
+1
+0.1% +$79 0.04% 121
2025
Q1
$136K Buy
1,517
+2
+0.1% +$187 0.05% 110
2024
Q4
$151K Buy
+1,515
New +$156K 0.05% 106

Other funds holding MRK

VSM Wealth Advisory's MRK Position: Q2 2026 in Review

VSM Wealth Advisory reduced its Merck (MRK) stake by 5.8% in Q2 2026, selling an estimated $4.92K and leaving 683 shares worth $87.8K. The position accounts for 0.02% of the portfolio, ranked #170.

VSM Wealth Advisory first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $151K in Q4 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • VSM Wealth Advisory held 683 shares of Merck worth $87.8K as of Q2 2026.
  • VSM Wealth Advisory sold 42 Merck shares in Q2 2026, an estimated $4.92K.
  • Merck made up 0.02% of VSM Wealth Advisory's portfolio in Q2 2026, its #170 holding.
  • VSM Wealth Advisory first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • VSM Wealth Advisory's Merck position peaked at $151K in Q4 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.